Key facts, as of
As of November 6, 2026, DaVita Inc. (DVA) trades at $191.35, up 57.5% over the past year. Its 52-week range runs from $101.00 to $247.49; the price is 22.7% below that high. It is 22.7% below its all-time high of $247.49, reached in August 2026. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +219.9%, against +316.3% for the S&P 500 (SPY). It sits 6.8% above its 200-day average of $179.10, and its 50-day average is above the 200-day too: an uptrend on both averages. Its 30-day volatility is 45.5% annualized, which we rate high risk. It has a trailing P/E of 14.5.
Cite: Portfolio Terminal, "DaVita Inc. (DVA) stock analysis", 2026-11-06. https://portfolio-terminal.com/analyse/dva
Where it trades today
trading 62% of the way up its 52-week range
How the price has moved
How far it is from its record
DaVita Inc. (DVA) is 22.7% below its all-time high of $247.49, reached in August 2026. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +219.9%, against +316.3% for the S&P 500 (SPY).
The read, from its own figures
What its numbers say
- DVA closes above its 50-day average ($182.59), and the 50-day sits above the 200-day ($179.10): on both averages the chart reads as an uptrend.
- At $191.35, DVA is 22.7% below its 1-year high of $247.49, set on August 3, 2026, and 89.5% above its 1-year low of $101.00 (January 14, 2026).
- Over the past month DVA rose 8.1%, from $177.02 to $191.35.
- DVA trades at 14.5x its last twelve months of earnings and 11.3x the next twelve months' estimate, so analysts expect earnings 27.7% higher.
- Its P/E is 17.8% above the 12.3x median of the 2 other medical care facilities companies we track (HCA, UHS).
- DVA's 30-day volatility, 45.5% a year, works out to a typical daily move of about 2.9%.
- Yahoo Finance puts its beta at 0.86: over five years of monthly returns, DVA moved about 0.86% for each 1% move of the S&P 500.
What would change the read
- A close under the 50-day average, $182.59 (−4.6% from the last close), would turn the read to a pullback; under the 200-day, $179.10 (−6.4%), the longer rise is in question.
- A close above $247.49 (+29.3%) would be a new 1-year high; below $101.00 (−47.2%), a new 1-year low.
How it is computed
- Prices are Yahoo Finance's daily candles for DVA, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
- The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
- Peers are the other companies Yahoo Finance files under medical care facilities among the assets we track, not a full industry screen; the median counts those with a positive P/E.
- Every sentence here is written by code from those figures, refreshed daily; nobody edits it for DVA by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.
Sources
- Yahoo Finance quote and daily historyopen →
The candles, the averages' inputs and the quote fields used for DVA. Last refresh: Nov 8, 2026, 10:53 PM UTC.
- How Portfolio Terminal computes its figuresopen →
The methodology page behind the analytics and their refresh cadence.
- Industry classification
Yahoo Finance's industry, as stored in our list of tracked assets: Medical Care Facilities.
What DaVita Inc. does
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements;…
What analysts expect
DVA carries a buy consensus from 7 analysts, with an average price target of $222.29 versus $191.35 today (+16.2%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
DVA generated $14.17B in trailing revenue (4.6% year over year), with a 6.5% net margin, and $905.08M of free cash flow, against $12.83B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $13.64B | $4.40B | $2.01B | $746.80M | $10.06 | $1.31B |
| 2024 | $12.82B | $4.22B | $1.95B | $936.34M | $11.02 | $1.47B |
| 2023 | $12.14B | $3.82B | $1.60B | $691.53M | $7.62 | $1.49B |
| 2022 | $11.61B | $3.40B | $1.31B | $560.40M | $6.03 | $961.14M |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
DVA is in 12 of the 54 ETFs we track. It weighs most in RSP: 0.20% of the fund, holding #197 of 504.
Famous investors who hold it
DVA is in the latest 13F of 1 of the 15 famous investors we follow. Warren Buffett (Berkshire Hathaway) holds the most of it: 2.15% of the portfolio, position #11 of 26, as of Q2 2026.
How its figures compare with those peers
Companies in the same industry
DVA beside the other companies Yahoo Finance files under medical care facilities among the assets we track (HCA, UHS, largest first).
DVAyou are here$191.35$12.04B
HCAHCA Healthcare$494.99$103.40B
UHSUniversal Health Services$195.50$11.52BWhat the chart is saying
In an uptrend, pressing toward $193.87 resistance.
uptrend- Price is 4.8% above its 50-day average and 6.8% above its 200-day.
- RSI at 56 is neither stretched nor washed out.
- The nearest ceiling is $193.87 (+1.3%), the nearest floor $171.90 (-10.2%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
How is DVA valued right now?
DaVita Inc. trades at 14.5 times its last twelve months of earnings and 11.3 times the next twelve months' estimate (Yahoo Finance, November 6, 2026). On the chart: in an uptrend, pressing toward $193.87 resistance. Price is 4.8% above its 50-day average and 6.8% above its 200-day.
What is the risk level of DVA?
Based on 30-day volatility of 45.5%, DVA has HIGH risk. Its beta of 0.86 means it has swung less than the S&P 500 over the last five years.
Does DVA pay dividends?
Yahoo Finance shows no dividend yield for DaVita Inc. (November 6, 2026).
How far is DVA from its all-time high?
DaVita Inc. is 22.7% below its all-time high of $247.49, reached in August 2026. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +219.9%, against +316.3% for the S&P 500 (SPY).
Which ETFs hold DVA?
12 of the 54 popular ETFs we track hold DaVita Inc.. The largest weights: RSP (0.20%), XLV (0.10%), VB (0.08%), SPY (<0.01%) and IVV (<0.01%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.
How much of VOO is DVA?
<0.01%, as of September 30, 2026: DVA is holding #496 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $0.09 in DaVita Inc..
Which famous investors own DVA?
Warren Buffett (2.15% of Berkshire Hathaway's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
Does Warren Buffett own DVA?
Yes. Berkshire Hathaway's 13F for Q2 2026, filed August 14, 2026, lists DaVita Inc. at 2.15% of the reported portfolio, position #11 of 26.
What is the analyst price target for DVA?
The average analyst price target for DaVita Inc. (DVA) is $222.29 based on 7 analyst estimates, about 16.2% above the current price of $191.35. The published range runs from $165.00 to $287.00.
How much revenue does DVA generate?
DaVita Inc. reported $14.17B in trailing twelve-month revenue. Revenue growth is running at 4.6% year over year. Net margin sits at 6.5%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare DVA with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.